Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de James A. Bristol
Age : 74
Public asset : 1,531,875 USD
Linked companies : Deciphera Pharmaceuticals, Inc. - Erasca, Inc.
Summary 
Currently, James A. Bristol holds the position of Chairman at Deciphera Pharmaceuticals, Inc. and Co-Chairman at Deciphera Pharmaceuticals LLC (a subsidiary of Deciphera Pharmaceuticals, Inc.) and Senior Advisor at Frazier Management LLC.

He is also on the board of Erasca, Inc. and Protypia, Inc. and Chairman-Medicinal Chemistry at Gordon Research Conferences.

He previously occupied the position of Senior Vice President-Worldwide Discovery Research at Pfizer Inc. Vice President-Discovery Research at Warner-Lambert Co. and Vice President-Discovery Research at Pfizer (St. Louis) (both are subsidiaries of Pfizer Inc.), Executive-in-Residence at Oxford Bioscience Partners and Member of The Polycystic Kidney Disease Research Foundation.

He received a doctorate from the University of New Hampshire and an undergraduate degree from Bates College.


Current positions of James A. Bristol 
NameTitle Since
Deciphera Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Chairman 2015
Erasca, Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Deciphera Pharmaceuticals LLC Co-Chairman 2007
Protypia, Inc. Director -
Gordon Research Conferences Chairman-Medicinal Chemistry -
Frazier Management LLC Senior Advisor 2009


Holdings of James A. Bristol 
NameEquities%Valuation
Erasca, Inc. (ERAS)
(Biotechnology & Medical Research)
187,5000.15%1,531,875 USD
Deciphera Pharmaceuticals, Inc. (DCPH)
(Biotechnology & Medical Research)
00.0000%0 USD


James A. Bristol: Personal Network 
Most Read News 
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
12/01Salesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
11/18Musk's pay trial asks if Tesla's growth justifies $56 billion compensation
RE
11/22'Boomerang CEOs' don't always work out; Disney hopes this one bucks trend
RE
11/21Musk says Twitter to hold off relaunching blue check verification
RE
11/19Musk's Twitter poll showing narrow majority want Trump reinstated
RE
More news


© 2022 People and Ownership :   
James A. Bristol : Connections